# Rainbow Children's Medicare Ltd (RAINBOW)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹1344.8
Day Change: +0.21%
52W High: ₹1645.7
52W Low: ₹1084
Market Cap: ₹13,708 Cr

## Valuation
P/E: 53.52
P/B: 9.04
EPS: ₹25.25
Book Value: ₹149.47
Dividend Yield: 0%

## Returns
1Y Return: -0.57%

## Profitability
ROE: 0%
ROCE: 19.76%
Debt/Equity: 0.53
Revenue Growth: 11.9%
Profit Growth: 5.6%
EBITDA Margin: 29.03%
Operating Margin: 24.1%

## About
Rainbow Children's Medicare Ltd is a Medical Care Facilities company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Medical Care Facilities
Sub Industry: Unknown

## Business Model
Overview: Rainbow Children's Medicare Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Care Facilities. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Compliances-Reg.24(A)-Annual Secretarial Compliance
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- BSE Filing: Compliances-Reg.24(A)-Annual Secretarial Compliance

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:04.699Z
Price History Updated: 2026-05-18T22:58:22.977Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:22.977Z
Quant Updated: 2026-05-18T22:58:22.977Z
Sentiment Updated: 2026-05-18T22:58:22.977Z
Financials Status: current
Financials Updated: 2026-05-18T10:30:40.544Z
Financials Last Attempt: 2026-05-18T10:30:40.544Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2015)
Revenue: ₹122 Cr
Operating Profit: ₹24 Cr (OPM 20%)
Net Profit: ₹5 Cr
Tax: ₹11 Cr

## Annual P&L History
Mar 2015: Rev ₹122Cr | PAT ₹5Cr | OPM 20%
Mar 2016: Rev ₹169Cr | PAT ₹25Cr | OPM 24%
Mar 2017: Rev ₹234Cr | PAT ₹17Cr | OPM 13%

## Balance Sheet (Mar 2015)
Total Assets: ₹201 Cr
Total Liabilities: ₹201 Cr
Borrowings: ₹24 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Ramesh  Kancharla M. D. Peds, Founder, Chairman, Managing Director and Chief of Gastro Enterology & Hepatology Unit
- Vikas  Maheshwari, Group Chief Financial Officer (KMP)
- Shreya  Mitra, Company Secretary & Compliance Officer
- Dinesh Kumar Chirla (Ped), DM, M.D., MRCPCH (UK), Whole-Time Director
- Abrarali  Dalal, Chief Executive Officer

---
Source: rupiya.io/stocks/rainbow
Disclaimer: For research and education only. Not investment advice.